In a word, we believe that our research results can provide new insights for the immunology of HER2-BC, and more and more rigorous experimental studies should be carried out in the next step to further explore the potential mechanism between ICs and the risk of HER2-BC. This evidence concerns the gene ERBB2 and breast cancer.